Pharmafile Logo
Pharmafocus logo
Advanced Search

Humira

Showing 15 posts of 90 posts found.

Amgen image

Late-stage successes for Amgen and Roche

February 5, 2015
Sales and Marketing Amgen, Bendamustine, Gazyva, Genentech, Humira, Levact, Napp, Roche, adalimumab, obinutuzumab

Roche and Amgen have both posted successful late-stage trial results that they say will contribute to their applications for regulatory …

News
Sandoz image

Sandoz earns historic first FDA biosimilar vote

January 8, 2015
Sales and Marketing FDA, Humira, Novartis, Sandoz, Zarxio, filgrastim, zarzio

Sandoz has taken a huge step forward in the race to be the first company to market a biosimilar in …

News

Humira biosimilar released in India

December 18, 2014
Research and Development, Sales and Marketing Humira, India, Zydus Cadila, anti-inflammatory, arthritis, bioscience

Indian firm Zydus Cadila has launched the first biosimilar of AbbVie’s anti-inflammatory medicine Humira, the world’s biggest-selling drug. Used as …

News
EMA image

EMA responds to redaction concerns

November 14, 2014
Sales and Marketing AbbVie, EMA, Goldacre, Humira, Rasi, adalimumab, redactions, transparency

The EMA has published a response to European Ombudsman Emily O’Reilly’s questions about some of its trial data redactions. O’Reilly’s …

News
Abbvie image

AbbVie financials beat expectations

October 31, 2014
Sales and Marketing AbbVie, Abbott, Creon, Humira, Iopinavir/ritonavir, Kaletra, Q3, Synthroid, levothyroxine, pancrelipase

AbbVie has announced higher-than-expected financial results for the third quarter of 2014, although it continues to rely heavily on blockbuster …

News
Shire image

AbbVie agrees to buy Shire for £32bn

July 18, 2014
Sales and Marketing AbbVie, Abbott, Humira, Shire, merger, new abbvie, takeover

Shire has accepted a £32 billion takeover deal from AbbVie after months of rejections and uncertainty. The firm, which is …

News
abbvie image

AbbVie a step closer to Shire takeover

July 14, 2014
Sales and Marketing ADHD, AbbVie, Abbott, Humira, Shire, hep C, takeover

Shire is recommending a new offer from suitor AbbVie that could finally see the US giant merge with the Dublin-based …

News
Shire image

AbbVie spells out Shire benefits

June 26, 2014
Sales and Marketing ADHD, AbbVie, Abbott, Humira, Shire, merger

AbbVie has spelt out exactly why it believes that Shire should accept its $46.5 billion bid. The US firm wants …

News
EMA image

EMA changes ‘on screen’ data policy

June 16, 2014
Medical Communications, Research and Development, Sales and Marketing AbbVie, EMA, Goldacre, Humira, alltrials, transparency

The European Medicines Agency is to formally agree its policy on the vexed issue of the publication of clinical trial …

News
Humira image

Humira drives AbbVie again

April 28, 2014
Sales and Marketing AbbVie, Abbott, Humira, RA

Rheumatoid arthritis treatment Humira has once more driven AbbVie, bringing in more than half the company’s sales in the first …

News
Abbvie image

AbbVie ‘pleased’ with first year

February 3, 2014
Sales and Marketing AbbVie, Abbott, CLL, EMA, HIV, Humira

Rheumatoid arthritis treatment Humira – as expected – has driven AbbVie in its first year as a standalone company, accounting …

News
Orencia image

Orencia matches Humira

June 13, 2013
Sales and Marketing AbbVie, Abbott, Humira, Orencia, RA

Bristol-Myers Squibb is hoping its biologic Orencia can grab a little more of the rheumatoid arthritis market after demonstrating non-inferiority …

News

Pfizer’s Xeljanz rejected in Europe

April 28, 2013
Sales and Marketing CHMP, Humira, Pfizer, RA, Xeljanz, rheumatoid arthritis

Pfizer has suffered a major setback with the rejection of its new arthritis drug in Europe.The EMA’s medicines committee the …

News
Humira image

AbbVie guards Humira data

March 13, 2013
Sales and Marketing AbbVie, Abbott, Humira, RA, transparency

AbbVie has issued two injunctions against the European Medicines Agency to prevent the regulator revealing data about rheumatoid arthritis drug …

News

AbbVie splits from Abbott

January 7, 2013
Sales and Marketing AbbVie, Abbott, HIV, Humira

AbbVie, the new $18 billion biopharma company which includes many of Abbott’s most high profile products, has finally launched. Abbott …

News

Latest content

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024